The stock has a 36-month beta value of 1.44. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CATX is 51.79M, and at present, short sellers hold a 12.81% of that float. On July 25, 2024, the average trading volume of CATX was 885.20K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CATX) stock’s latest price update
The stock price of Perspective Therapeutics Inc (AMEX: CATX) has surged by 2.42 when compared to previous closing price of 12.82, but the company has seen a 10.43% gain in its stock price over the last five trading sessions. investorplace.com reported 2024-07-25 that Nvidia (NASDAQ: NVDA ) is having a fantastic year in the markets, up 156% in 2024. That follows a 2023 return of 239%.
CATX’s Market Performance
Perspective Therapeutics Inc (CATX) has experienced a 10.43% rise in stock performance for the past week, with a 37.49% rise in the past month, and a -22.31% drop in the past quarter. The volatility ratio for the week is 5.06%, and the volatility levels for the past 30 days are at 8.29% for CATX. The simple moving average for the last 20 days is 13.73% for CATX stock, with a simple moving average of 46.01% for the last 200 days.
CATX Trading at 3.10% from the 50-Day Moving Average
After a stumble in the market that brought CATX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.08% of loss for the given period.
Volatility was left at 8.29%, however, over the last 30 days, the volatility rate increased by 5.06%, as shares surge +37.85% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.66% lower at present.
During the last 5 trading sessions, CATX rose by +10.26%, which changed the moving average for the period of 200-days by +340.52% in comparison to the 20-day moving average, which settled at $11.72. In addition, Perspective Therapeutics Inc saw 226.62% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CATX starting from Hunt Jonathan Robert, who purchase 1,800 shares at the price of $9.81 back on Jun 17 ’24. After this action, Hunt Jonathan Robert now owns 35,971 shares of Perspective Therapeutics Inc, valued at $17,667 using the latest closing price.
Woods Lori A, the Director of Perspective Therapeutics Inc, purchase 4,587 shares at $10.90 during a trade that took place back on Jun 14 ’24, which means that Woods Lori A is holding 159,985 shares at $49,990 based on the most recent closing price.
Stock Fundamentals for CATX
Current profitability levels for the company are sitting at:
- -6.32 for the present operating margin
- 0.07 for the gross margin
The net margin for Perspective Therapeutics Inc stands at -4.17. The total capital return value is set at -0.32. Equity return is now at value -29.53, with -27.07 for asset returns.
Based on Perspective Therapeutics Inc (CATX), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -8.44. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -551.88.
Currently, EBITDA for the company is -14.84 million with net debt to EBITDA at 0.47. When we switch over and look at the enterprise to sales, we see a ratio of 168.38. The receivables turnover for the company is 3.03for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 12.98.
Conclusion
To sum up, Perspective Therapeutics Inc (CATX) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
